Literature DB >> 8092206

Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin.

B J van der Heijden1, C Carlus, F Narcy, F Bavoux, A L Delezoide, M C Gubler.   

Abstract

OBJECTIVE: The purpose of this study is to emphasize the high risk of renal failure and severe morphologic changes related to prolonged prenatal exposure to indomethacin. STUDY
DESIGN: Referred renal specimens from six anuric neonates exposed in utero to indomethacin were studied. Clinical charts were retrospectively reviewed. Indomethacin dosages varied from 150 to 400 mg daily, and the drug was given for a 2- to 11-week period, until birth.
RESULTS: All infants died in anuria, 4 of them after 7 to 39 days on peritoneal dialysis. In 5 infants cystic dilatations of superficial nephrons were associated with ischemic changes of the deep cortex. By immunohistochemical analysis intrarenal renin content was increased in 4 of 5 patients.
CONCLUSION: Long-term indomethacin treatment during pregnancy may lead to the development of renal failure and irreversible renal damage with cystic dilatation of developing nephrons in an exposed fetus. Prior stimulation of the renin-angiotensin system may favor this complication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092206     DOI: 10.1016/0002-9378(94)90073-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy.

Authors:  S Campbell; A Clohessy; C O'Brien; S Higgins; M Higgins; F McAuliffe
Journal:  Obstet Med       Date:  2017-01-29

Review 2.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents.

Authors:  B van der Heijden; M C Gubler
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 4.  NSAID-induced nephrotoxicity from the fetus to the child.

Authors:  L Cuzzolin; M Dal Cerè; V Fanos
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

5.  Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors.

Authors:  Anke Olliges; Stefanie Wimmer; Rolf M Nüsing
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Effects of ibuprofen treatment on the developing preterm baboon kidney.

Authors:  Megan R Sutherland; Bradley A Yoder; Donald McCurnin; Steven Seidner; Lina Gubhaju; Ronald I Clyman; M Jane Black
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-22

7.  Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.

Authors:  Joseph T Azzarello; Hsueh-Kung Lin; Awet Gherezghiher; Vladislav Zakharov; Zhongxin Yu; Bradley P Kropp; Daniel J Culkin; Trevor M Penning; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2009-11-15

Review 8.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

9.  The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn.

Authors:  Alfred Drukker
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

10.  Postnatal regulation of 15-hydroxyprostaglandin dehydrogenase in the rat kidney.

Authors:  Ying Liu; Zhanjun Jia; Ying Sun; Li Zhou; Maicy Downton; Ren Chen; Aihua Zhang; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.